COLORADO SPRINGS, Colo., July 29, 2013 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that it will be participating in two upcoming conferences.
Spectranetics management is scheduled to present at the Canaccord Genuity 33rd Annual Growth Conference in Boston on Wednesday, August 14, 2013 at 9:00 am ET. Interested parties can access the live audio webcast at http://www.spectranetics.com. An archived presentation will be available on the Web site for 30 days.
Spectranetics management is scheduled to participate in the 2nd Annual Piper Jaffray Heartland Summit in Minneapolis on August 15, 2013.
About Spectranetics
Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in more than 40 countries and are used to treat arterial blockages in the heart and legs, as well as the removal of pacemaker and defibrillator leads.
The Company's Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration and thrombectomy catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.
The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.
CONTACT: The Spectranetics Corporation
Guy Childs, Chief Financial Officer
(719) 633-8333
INVESTOR CONTACTS
Westwicke Partners
Lynn Pieper
(415) 202-5678
lynn.pieper@westwicke.com
